CIK 0000920148
- Large accelerated filer
LABCORP HOLDINGS INC.
Sign in to watch- Ticker
- LH
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 992588107
- Phone
- +1 336-229-1127
- Business address
- 358 S MAIN ST, BURLINGTON, NC, 27215
- Former names
- LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,377,699
- in 4 filings, $108K under 10b5-1 plans
Net −$1,377,699. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-02 | Schechter Adam H President & CEO | Shares withheld for taxes | −822 | $221.54 | $182K | 49,160 |
| 2024-02-02 | Schechter Adam H President & CEO | Exercise or conversion · Restricted Stock Unit | −3,094 | 88,111 | ||
| 2024-02-02 | DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl | Exercise or conversion | +246 | 3,600.55 | ||
| 2024-02-02 | DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl | Shares withheld for taxes | −85 | $221.54 | $19K | 3,515.55 |
| 2024-02-02 | DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl | Exercise or conversion · Restricted Stock Unit | −246 | 4,560 | ||
| 2024-02-02 | EISENBERG GLENN A Chief Financial Officer, EVP | Exercise or conversion | +856 | 43,032 | ||
| 2024-02-02 | EISENBERG GLENN A Chief Financial Officer, EVP | Shares withheld for taxes | −228 | $221.54 | $51K | 42,804 |
| 2024-02-02 | EISENBERG GLENN A Chief Financial Officer, EVP | Exercise or conversion · Restricted Stock Unit | −856 | 34,531 | ||
| 2024-02-02 | Schroeder Mark S EVP, Pres Diagnostics & COO | Exercise or conversion | +495 | 7,253.14 | ||
| 2024-02-02 | Schroeder Mark S EVP, Pres Diagnostics & COO | Shares withheld for taxes | −132 | $221.54 | $29K | 7,121.14 |
| 2024-02-02 | Schroeder Mark S EVP, Pres Diagnostics & COO | Exercise or conversion · Restricted Stock Unit | −495 | 14,543 | ||
| 2024-02-02 | van der Vaart Sandra D EVP, Chief Legal Officer | Exercise or conversion 10b5-1 | +264 | 7,900.98 | ||
| 2024-02-02 | van der Vaart Sandra D EVP, Chief Legal Officer | Shares withheld for taxes 10b5-1 | −71 | $221.54 | $16K | 7,829.98 |
| 2024-02-02 | van der Vaart Sandra D EVP, Chief Legal Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −264 | 7,865 | ||
| 2023-12-15 | DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl | Exercise or conversion | +64 | 3,373.55 | ||
| 2023-12-15 | DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl | Shares withheld for taxes | −19 | $219.50 | $4K | 3,354.55 |
| 2023-12-15 | DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl | Exercise or conversion · Restricted Stock Unit | −64 | 4,806 | ||
| 2023-11-16 | Wilkinson Peter J SVP, Chief Accounting Officer | Sale | −1,384 | $210.71 | $292K | 2,087.22 |
| 2023-10-12 | Kliphouse Kirsten Marie Director | Exercise or conversion | +372 | 372 | ||
| 2023-10-12 | Kliphouse Kirsten Marie Director | Exercise or conversion · Restricted Stock Unit | −372 | 947 |
Page 35 of 41 · 816 trades